General information | Good outcome (n = 249, 81.4%) | Poor outcome (n = 57,18.6%) | χ2 value or Fisher’s exact | P value |
---|---|---|---|---|
Age | 0.444 | 0.505 | ||
≤ 30 years | 93 | 24 | ||
> 30 years | 156 | 33 | ||
Age range (years) | 15–63 | 14–58 | ||
Sex | 1.928 | 0.165 | ||
Male | 132 | 36 | ||
Female | 117 | 21 | ||
Onset of CVST | 2.827 | 0.243 | ||
Acute | 49 | 17 | ||
Subacute | 159 | 32 | ||
Chronic | 41 | 8 | ||
Etiology | ||||
Pregnancy/puerperium | 18 | 9 | 0.302 | 0.583 |
Infection | 9 | 4 | 1.320 | 0.251 |
Cerebral infarction | 18 | 3 | 0.280 | 0.596 |
Autoimmune diseases | 6 | 1 | 0.089 | 0.765 |
Thrombotic diseases | 27 | 5 | 0.213 | 0.645 |
Unknown reason | 33 | 6 | 0.310 | 0.578 |
Clinical manifestations | 71.808 | 0.000 | ||
Headache, dizziness | 210 | 45 | 0.970 | 0.325 |
Seizure | 13 | 26 | 68.051 | 0.000 |
Hemiplegia | 15 | 12 | 11.937 | 0.001 |
Aphasia | 3 | 0 | 1.244 | 0.265 |
Visual loss | 12 | 0 | 0.182 | 0.669 |
GCS | 59.120 | 0.000 | ||
3–8 | 6 | 19 | ||
9–15 | 243 | 38 | ||
Midline shift | 128.402 | 0.000 | ||
< 0.5 | 243 | 24 | ||
> 0.5 | 6 | 33 |